Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.44B |
| 2 |
Microsoft
MSFT
|
+$556M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$433M |
| 4 |
Johnson & Johnson
JNJ
|
+$349M |
| 5 |
Amazon
AMZN
|
+$340M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$873M |
| 2 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$799M |
| 3 |
Colgate-Palmolive
CL
|
+$602M |
| 4 |
Palo Alto Networks
PANW
|
+$574M |
| 5 |
iShares US Real Estate ETF
IYR
|
+$405M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.33% |
| 2 | Financials | 13.77% |
| 3 | Healthcare | 12.44% |
| 4 | Consumer Discretionary | 10.89% |
| 5 | Communication Services | 7.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Exelixis
EXEL
$13.3B
| $5.37M | 0.01% |
342,442
-291,341
| -46% | -$5.63M |
|
|
IRRX
1102
DELISTED
Integrated Rail and Resources Acquisition Corp.
IRRX
| $5.36M | 0.01% |
532,400
| – | – |
|
1103
Acadia Pharmaceuticals
ACAD
$4.43B
| $5.35M | 0.01% |
327,047
+221,781
| +211% | +$3.59M |
|
1104
Progress Software
PRGS
$1.66B
| $5.31M | 0.01% |
124,774
+184
| +0.1% | +$8.5K |
|
1105
Lear
LEA
$6.54B
| $5.31M | 0.01% |
44,344
+2,918
| +7% | +$403K |
|
1106
UGI
UGI
$7.74B
| $5.3M | 0.01% |
163,952
+10,898
| +7% | +$430K |
|
|
DTRT
1107
DELISTED
DTRT Health Acquisition Corp. Class A Common Stock
DTRT
| $5.3M | 0.01% |
521,762
+321,762
| +161% | +$3.25M |
|
1108
ASE Group
ASX
$77.3B
| $5.3M | 0.01% |
1,061,386
+476,547
| +81% | +$2.68M |
|
1109
CALL
Chegg
CHGG
$110M
| $5.27M | 0.01% |
250,000
| – | – |
|
1110
Burlington
BURL
$23.2B
| $5.26M | 0.01% |
47,064
+6,307
| +15% | +$919K |
|
|
SWT
1111
DELISTED
Stanley Black & Decker, Inc.
SWT
| $5.23M | 0.01% |
106,127
+72,827
| +219% | +$4.52M |
|
1112
Shift4
FOUR
$4.2B
| $5.23M | 0.01% |
117,290
-10,304
| -8% | -$433K |
|
1113
iShares MSCI United Kingdom ETF
EWU
$4.14B
| $5.23M | 0.01% |
199,518
+23,269
| +13% | +$683K |
|
1114
Performance Food Group
PFGC
$18B
| $5.23M | 0.01% |
121,681
+55,491
| +84% | +$2.74M |
|
1115
iShares MSCI Japan ETF
EWJ
$21.9B
| $5.22M | 0.01% |
106,840
-35,798
| -25% | -$1.92M |
|
1116
Allison Transmission
ALSN
$9.5B
| $5.21M | 0.01% |
154,399
-71,163
| -32% | -$2.66M |
|
|
1117
Chegg
CHGG
$110M
| $5.21M | 0.01% |
247,232
-7,912
| -3% | -$164K |
|
1118
Peloton Interactive
PTON
$2.77B
| $5.2M | 0.01% |
750,670
-202,544
| -21% | -$2.06M |
|
|
EAC
1119
DELISTED
Edify Acquisition Corp. Class A Common Stock
EAC
| $5.2M | 0.01% |
525,762
+28,000
| +6% | +$276K |
|
|
LTC
1120
LTC Properties
LTC
$2.06B
| $5.2M | 0.01% |
138,721
+51,840
| +60% | +$2.16M |
|
1121
Advanced Drainage Systems
WMS
$10.6B
| $5.19M | 0.01% |
41,759
+18,707
| +81% | +$2.33M |
|
|
AAT
1122
American Assets Trust
AAT
$1.45B
| $5.19M | 0.01% |
201,756
-5,860
| -3% | -$168K |
|
|
IIVI
1123
DELISTED
Coherent Corp. 6.00% Series A Mandatory Convertible Preferred Stock
IIVI
| $5.19M | 0.01% |
33,149
-1,528
| -4% | -$311K |
|
1124
BioCryst Pharmaceuticals
BCRX
$2.28B
| $5.18M | 0.01% |
411,516
+324,633
| +374% | +$4.18M |
|
1125
Beam Therapeutics
BEAM
$2.63B
| $5.18M | 0.01% |
108,736
+78,267
| +257% | +$4.46M |
|
Similar funds
Barclays's Q3 2022 Portfolio in Review
As of Q3 2022, Barclays held 5,400 positions worth $91.6B, down 44% from $163B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Barclays withdrew a net $66.4B in Q3 2022, closing 533 positions and reducing 1,954 holdings. Its most notable exit was Vonage Holdings Corporation, an estimated $99.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Barclays opened a new position in Pacer iPath Gold ETNs worth $27.1M.
- Barclays's largest Q3 2022 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $27.1M.
- Barclays added most to Apple in Q3 2022, an estimated $1.44B increase.
- Barclays's biggest Q3 2022 reduction was Invesco QQQ Trust, cutting an estimated $873M.
- Barclays fully exited Vonage Holdings Corporation in Q3 2022, selling an estimated $99.4M.
- Barclays's ten largest holdings make up 22% of its $91.6B portfolio in Q3 2022.
- Barclays opened 261 new positions and closed 533 in Q3 2022.
- Barclays's portfolio value fell 44% quarter-over-quarter to $91.6B.
Based on Barclays's 13F filing for Q3 2022, filed 3 Nov 2022.